Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Positive Ph Acute Lymphoblastic Leucemia With Intensive Induction Chemotherapy and Glivec, Before and After the Hematopoetic Progenitor Transplant

NCT00388895 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT00388895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00388895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Positive Ph Acute Lymphoblastic Leucemia With Intensive Induction Chemotherapy and Glivec, Before and After the Hematopoetic Progenitor Transplant
Lead sponsor
PETHEMA Foundation
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2002
Completion date
October 31, 2007
Enrollment
35
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, cromosome philadelphia positive